Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">On The Wires<ul><li>iBio, Inc. (<strong>IBIO</strong>) On January 20, 2017, the Supreme Court for the State of New York, County of New York, scheduled a hearing to consider approval of a settlement of the derivative action captioned Spencer Savage and Yousef Barakat, Derivatively on Behalf of iBio, Inc., Plaintiffs, v. Robert B. Kay, Arthur Y. Elliott, James T. Hill, Glenn Chang, Philip K. Russell, John D. McKey, and Seymour Flug, Defendants, and iBio, Inc., Nominal Defendant, Index No. 162407 / 2015 (N.Y. Sup. Ct.). That action has been settled according to the terms of a Stipulation of Settlement dated as of September 20, 2016 (the «Stipulation»). The Stipulation provides, among other things, for the implementation of certain «Corporate Governance Changes,» and that iBio will not oppose an application by the plaintiffs' attorneys to the Court for an award, not to exceed $160,000, of fees, expenses, and $2,000 for each of the two named plaintiffs, inclusive. iBio expects that the payment of such an award will be funded by the Company's insurance carrier.</li><li>NXP Semiconductors N.V. (<strong>NXPI</strong>) announced that, during an extraordinary general meeting of shareholders held today, NXP obtained shareholder approval for all items proposed relating to the previously disclosed tender offer by Qualcomm (<strong>QCOM</strong>) to acquire all of the outstanding shares of NXP. The transaction is expected to close by the end of calendar 2017.</li><li>Seagate Technology (<strong>STX</strong>) disclosed in a regulatory filing that it plans to meet with potential investors on or about January 30, 2017. Subject to market conditions, the Company expects that there will follow a U.S. dollar-denominated offering of notes in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended, and to non-U.S. persons outside the United States under Regulation S under the Securities Act. The notes are expected to be issued by a subsidiary of the Company and guaranteed by the Company.</li></ul></td> </tr></table>"